Global Vaccines
Market Report
2025
As per Cognitive Market Research's latest published report, the Global Vaccines market size was USD 68.57 Billion in 2022 and it is forecasted to reach USD 155.39 Billion by 2030. Vaccines Industry's Compound Annual Growth Rate will be 10.8% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Vaccines Market Report 2025.
As per Cognitive Market Research's latest published report, the Global Vaccines market size was USD 68.57 Billion in 2022 and it is forecasted to reach USD 155.39 Billion by 2030. Vaccines Industry's Compound Annual Growth Rate will be 10.8% from 2023 to 2030.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Vaccines Market Sales Revenue | 121212 | 121212 | 121212 | 10.8% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by Technology |
|
Market Split by Age Group |
|
Market Split by Type of Diseases |
|
Market Split by Route of Administration |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Vaccines industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Vaccines Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
A preparation that is used to stimulate the body’s immune response against diseases is referred to as a vaccine. Most vaccines are given by needle injection, although some can also be taken by mouth or sprayed into the nose. Immune responses that fight illness are produced when the immune system is stimulated by vaccines. A vaccine typically consists of an agent that resembles disease-causing microbes and is made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. This agent stimulates the immune system to recognize the agent as a threat, destroy it, and further recognize and destroy any microorganisms associated with that agent that it may encounter in the future.
The increasing prevalence of emerging and re-emerging infectious diseases, and introduction of several vaccination programs by governments across various endemic regions, and the increased sensitivity of the geriatric & pediatric population to lethal diseases are the major driving factors for the growth of the vaccines market. The demand for vaccines is further stimulated by the growing involvement of numerous international organizations, including WHO, UNICEF, World Bank, Bill & Melinda Gates Foundation, etc. in developing suitable immunization facilities in endemic regions.
Further, increasing investment in research and development by the different governments and companies for vaccine preparation will create lucrative opportunities for the vaccine market. However, the high cost of several vaccines per dose limits the vaccine market’s growth. For instance, the cost of the vaccines for hepatitis A/Hepatitis B, Infanrix is higher, which can limit the growth of the market in developing or low-income nations.
We have various report editions of Vaccines Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
Bharat Biotech: India launched its first nasal Covid vaccine (January 2023)
Made by Bharat Biotech, iNCOVACC is administered in the form of drops and stimulates an immune response in the tissues that line the nasal cavity. The vaccine will cost 800 rupees ($10; £8) per dose in private hospitals and 325 rupees per dose in government hospitals.
Top Companies Market Share in Vaccines Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America is estimated as the largest market for vaccines and is projected to grow with the highest CAGR during the forecast period, owing to the increased research and development investment in vaccines, strong awareness about vaccines, and the presence of major manufacturers. On the other hand, the APAC region is expected to witness tremendous growth in the market. This is due to the growing population in developing economies like India, China, and others, increasing healthcare expenditure, and government initiatives regarding vaccines in rural areas.
The current report Scope analyzes Vaccines Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Vaccines Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Vaccines Industry growth. Vaccines market has been segmented with the help of its Type, Application Technology, and others. Vaccines market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Vaccines analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Vaccines Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key Application of Vaccines are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Vaccines Market is witnessing significant growth in the near future.
In 2023, the Combination Vaccines segment accounted for noticeable share of global Vaccines Market and is projected to experience significant growth in the near future.
The Community Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies GSK, Merck and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Combination Vaccines, Monovaccines |
Application | Community Hospitals, Hospitals, Specialty Centres, Clinics, Others |
Technology | Recombinant Vaccines, Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines |
Age Group | Pediatric Vaccine, Adult Vaccine |
Type of Diseases | Pneumococcal Disease, Measles, Mumps, Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others |
Route of Administration | Injectable, Oral, Nasal |
List of Competitors | GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune  LLC, J&J Crucell, China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan |
This chapter will help you gain GLOBAL Market Analysis of Vaccines. Further deep in this chapter, you will be able to review Global Vaccines Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Vaccines. Further deep in this chapter, you will be able to review North America Vaccines Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Vaccines. Further deep in this chapter, you will be able to review Europe Vaccines Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Vaccines. Further deep in this chapter, you will be able to review Asia Pacific Vaccines Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Vaccines. Further deep in this chapter, you will be able to review South America Vaccines Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Vaccines. Further deep in this chapter, you will be able to review Middle East Vaccines Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Vaccines. Further deep in this chapter, you will be able to review Middle East Vaccines Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Vaccines. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Technology Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Age Group Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Type of Diseases Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by Route of Administration Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Vaccines market
Chapter 16 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 17 Research Methodology and Sources
Why Combination Vaccines have a significant impact on Vaccines market? |
What are the key factors affecting the Combination Vaccines and Monovaccines of Vaccines Market? |
What is the CAGR/Growth Rate of Community Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Vaccines Market? |
Which region is expected to dominate the global Vaccines Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|